- Home
- SPRY vs REAX Comparison
SPRY vs REAX Comparison
Compare SPRY & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRY
- REAX
- Stock Information
- Founded
- SPRY 2015
- REAX 2018
- Country
- SPRY United States
- REAX United States
- Employees
- SPRY N/A
- REAX N/A
- Industry
- SPRY Biotechnology: Pharmaceutical Preparations
- REAX
- Sector
- SPRY Health Care
- REAX
- Exchange
- SPRY Nasdaq
- REAX Nasdaq
- Market Cap
- SPRY 1.4B
- REAX 1.1B
- IPO Year
- SPRY N/A
- REAX N/A
- Fundamental
- Price
- SPRY $11.41
- REAX $4.99
- Analyst Decision
- SPRY Strong Buy
- REAX Strong Buy
- Analyst Count
- SPRY 4
- REAX 2
- Target Price
- SPRY $24.00
- REAX $5.25
- AVG Volume (30 Days)
- SPRY 959.4K
- REAX 773.3K
- Earning Date
- SPRY 11-13-2024
- REAX 11-07-2024
- Dividend Yield
- SPRY N/A
- REAX N/A
- EPS Growth
- SPRY N/A
- REAX N/A
- EPS
- SPRY N/A
- REAX N/A
- Revenue
- SPRY $2,568,000.00
- REAX $1,095,350,000.00
- Revenue This Year
- SPRY $95,526.66
- REAX $79.06
- Revenue Next Year
- SPRY $275.98
- REAX $30.06
- P/E Ratio
- SPRY N/A
- REAX N/A
- Revenue Growth
- SPRY 8460.00
- REAX 81.37
- 52 Week Low
- SPRY $5.02
- REAX $1.46
- 52 Week High
- SPRY $18.51
- REAX $6.75
- Technical
- Relative Strength Index (RSI)
- SPRY 32.88
- REAX 41.36
- Support Level
- SPRY $11.76
- REAX $4.83
- Resistance Level
- SPRY $14.50
- REAX $5.35
- Average True Range (ATR)
- SPRY 0.75
- REAX 0.23
- MACD
- SPRY -0.20
- REAX -0.03
- Stochastic Oscillator
- SPRY 1.63
- REAX 13.59
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
About REAX The Real Brokerage Inc.
The Real Brokerage Inc is a technology-powered real estate brokerage firm. It has developed, integrated, and adopted various mobile and desktop-focused technologies to create a comprehensive offering to its agents and to assist Real with its brokerage operations. The group delivers a cloud-based platform to improve efficiencies and empower real estate agents to provide a seamless end-to-end experience for homebuyers and sellers. The company generates its maximum revenue from the United States.